AAQL Posts $1.03M Revenue, Widening Losses as It Pivots to Health Products
AAQL filed a Earnings and Guidance on light trading volume (0.1× avg).
Summary
Antiaging Quantum Living reported FY 2026 revenue of $1.03M, a 26% increase from the prior year, but net loss widened to $837.6K from $720.4K. The company is pivoting away from its online platform business, completing a phased shutdown between September 2025 and January 2026, to focus on proprietary health and beauty products and therapy services. Gross margins improved to 67.9% on the new offerings, but near-term margin pressure persists as it retains centralized staff. The 10-K also disclosed a going concern warning and material weaknesses in internal controls, underscoring significant financial risk. With a market cap around $20M and cash burn ongoing, the strategic shift is high-stakes.
At the time of this announcement, AAQL was trading at $0.60 on OTC in the Life Sciences sector, with a market capitalization of approximately $20.7M. The 52-week trading range was $0.02 to $7.02. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: Wiseek News.